4//SEC Filing
ROYSTON IVOR 4
Accession 0001209191-23-036024
CIK 0001061027other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 6:34 PM ET
Size
5.8 KB
Accession
0001209191-23-036024
Insider Transaction Report
Form 4
ROYSTON IVOR
DirectorCEO & President
Transactions
- Award
Stock Option (Right to Buy)
2023-06-08+40,000→ 40,000 totalExercise: $1.50Exp: 2033-06-08→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]1/12th of the shares subject to the option shall vest each month following the date of grant, or if earlier 100% of the shares subject to the option shall vest on the date of the Issuer's next annual stockholder meeting, in each case subject to the reporting person remaining a Service Provider (as defined in the 2021 Equity Incentive Plan) through the applicable vesting date.
Documents
Issuer
Viracta Therapeutics, Inc.
CIK 0001061027
Entity typeother
Related Parties
1- filerCIK 0001026765
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 6:34 PM ET
- Size
- 5.8 KB